Riverain Technologies

Riverain Technologies is a medical software company specializing in artificial intelligence solutions for cardiothoracic imaging interpretation. The company develops the ClearRead product suite, which includes ClearRead CT Chest and ClearRead Xray—AI-powered diagnostic tools designed to streamline chest CT and X-ray reading workflows while improving diagnostic accuracy and clinician confidence. ClearRead CT targets pulmonary nodule detection and coronary artery calcification (CAC) scoring in chest CT examinations. ClearRead Xray provides bone-suppression imaging and detection capabilities for pulmonary nodules and pneumothorax on chest radiographs. The solutions are built on advanced deep-learning algorithms that quantify population health metrics and reduce cognitive burden on radiologists. Riverain serves over 400 customer locations globally, including major academic medical centers (Cleveland Clinic, Duke Health, University of Chicago Medicine, University Hospital Zurich, UW Health), health systems (Northwestern Medicine, Cedars-Sinai, VA), and diagnostic imaging practices. The company emphasizes clinical validation through peer-reviewed publications, case studies, and real-world deployment across international healthcare institutions. Riverain's focus is on improving patient outcomes in lung cancer screening and early detection, pneumothorax identification, and cardiovascular risk assessment through workflow optimization and decision support.